Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target

por Kobayashi, Eiji, Kondo, Satoru, Dochi, Hirotomo, Moriyama-Kita, Makiko, Hirai, Nobuyuki, Komori, Takeshi, Ueno, Takayoshi, Nakanishi, Yosuke, Hatano, Miyako, Endo, Kazuhira, Sugimoto, Hisashi, Wakisaka, Naohiro, Yoshizaki, Tomokazu
Publicado 2022

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma

por Kase, Kina, Kondo, Satoru, Wakisaka, Naohiro, Dochi, Hirotomo, Mizokami, Harue, Kobayashi, Eiji, Kano, Makoto, Komori, Takeshi, Hirai, Nobuyuki, Ueno, Takayoshi, Nakanishi, Yosuke, Hatano, Miyako, Endo, Kazuhira, Moriyama-Kita, Makiko, Sugimoto, Hisashi, Yoshizaki, Tomokazu
Publicado 2021

EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non‐endemic region

por Kondo, Satoru, Okuno, Yusuke, Murata, Takayuki, Dochi, Hirotomo, Wakisaka, Naohiro, Mizokami, Harue, Moriyama‐Kita, Makiko, Kobayashi, Eiji, Kano, Makoto, Komori, Takeshi, Hirai, Nobuyuki, Ueno, Takayoshi, Nakanishi, Yosuke, Endo, Kazuhira, Sugimoto, Hisashi, Kimura, Hiroshi, Yoshizaki, Tomokazu
Publicado 2022

Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma

por Dochi, Hirotomo, Kondo, Satoru, Murata, Takayuki, Fukuyo, Masaki, Nanbo, Asuka, Wakae, Kousho, Jiang, Wen‐Ping, Hamabe‐Horiike, Toshihide, Tanaka, Mariko, Nishiuchi, Takumi, Mizokami, Harue, Moriyama‐Kita, Makiko, Kobayashi, Eiji, Hirai, Nobuyuki, Komori, Takeshi, Ueno, Takayoshi, Nakanishi, Yosuke, Hatano, Miyako, Endo, Kazuhira, Sugimoto, Hisashi, Wakisaka, Naohiro, Juang, Shin‐Hun, Muramatsu, Masamichi, Kaneda, Atsushi, Yoshizaki, Tomokazu
Publicado 2022